XELOX for Metastatic Breast Cancer

Clinical trial NCT00204776 · COMPLETED

Trial details

NCT number: NCT00204776
Sponsor: University of Wisconsin, Madison
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2005-03-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.